Please use this identifier to cite or link to this item:
Title: A Case Report of Compound Heterozygosity for β<sup>0</sup>/β<sup>+</sup>-Thalassemia Resulting from under Diagnosed β-Thalassemia Found in a Hb A'<inf>2</inf> Sample
Authors: Nutjeera Intasai
Ampai Phasit
Sitthichai Panyasai
Sakorn Pornprasert
Keywords: Biochemistry, Genetics and Molecular Biology
Issue Date: 2-Jan-2019
Abstract: © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group. Hb A'2 (or Hb B2) (HBD: c.49G>C) is the most frequent δ chain variant that has been described in Africa but not in Thailand. We report here a 10-month-old Thai infant with compound heterozygosity for β0 codon 17 (A>T; HBB: c.52A>T) and β+ IVS II-654 (C>T; HBB: c.316-197C>T). Under diagnosed β-thalassemia (β-thal) in her father, who carries Hb A'2 and a heterozygous β0 codon 17 mutation, and the mother, who carries a heterozygous β+ IVS II-654 mutation, was noted. Although Hb A'2 does not cause any problems, heterozygosity for Hb A'2 can lead to under diagnosis of β-thal in Hb A'2 samples. This case highlights the importance of Hb A'2 in prenatal diagnosis (PND). Thus, molecular analysis for β-thal mutations should be carried out when a small peak presents at the retention time (RT) of 4.71 min. on high performance liquid chromatography (HPLC) and the summation level of this peak and Hb A2 was equal or higher than 4.0%.
ISSN: 1532432X
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.